Jim Simons acquired 579 Thousand Esperion Therapeutics shares worth $517 Thousand. That's 0.00% of their equity portfolio (2500th largest holding). The first Esperion Therapeutics trade was made in Q4 2015. Since then Jim Simons bought shares ten more times and sold shares on twelve occasions. The investor's estimated purchase price is $973 Thousand, resulting in a loss of 47%.